No results for ‘’
Sun Pharmaceutical Industries Ltd
₹1792.50
(0.34%)
Mon, 15 Jun 2026, 08:33 am
Health Technology
Pharmaceuticals: Major
24.5KSun Pharmaceutical Industries Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 |
| FII | 15.94 | 16.12 | 16.55 | 17.26 | 17.96 |
| DII | 21.11 | 20.82 | 20.23 | 19.50 | 18.70 |
| Public | 8.48 | 8.58 | 8.73 | 8.77 | 8.87 |
| Government | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Sun Pharmaceutical Industries Ltd Shareholding Pattern
The Sun Pharmaceutical Industries Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Sun Pharmaceutical Industries Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Sun Pharmaceutical Industries Ltd (NSE: SUNPHARMA, BSE: 524715) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Sun Pharmaceutical Industries Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Sun Pharmaceutical Industries Ltd Shareholding Pattern (Latest)
The latest Sun Pharmaceutical Industries Ltd shareholding for Mar 2026 is:
- Promoters: 54.48%
- FII: 15.94%
- DII: 21.11%
- Public: 8.48%
- Government: 0.00%
Promoter holding in Sun Pharmaceutical Industries Ltd remains stable, reflecting consistent long-term commitment.
Sun Pharmaceutical Industries Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Sun Pharmaceutical Industries Ltd.
- Mar 2026: 54.48%
- Dec 2025: 54.48%
- Sept 2025: 54.48%
- Jun 2025: 54.48%
- Mar 2025: 54.48%
Promoter stake remains largely stable, showing consistent ownership structure.
Sun Pharmaceutical Industries Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Sun Pharmaceutical Industries Ltd.
- Mar 2026: 15.94%
- Dec 2025: 16.12%
- Sept 2025: 16.55%
- Jun 2025: 17.26%
- Mar 2025: 17.96%
FII holding has declined, suggesting cautious sentiment among foreign investors.
Sun Pharmaceutical Industries Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Mar 2026: 21.11%
- Dec 2025: 20.82%
- Sept 2025: 20.23%
- Jun 2025: 19.50%
- Mar 2025: 18.70%
DII stake in Sun Pharmaceutical Industries Ltd has increased over time, indicating growing domestic institutional confidence.
Sun Pharmaceutical Industries Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Mar 2026: 8.48%
- Dec 2025: 8.58%
- Sept 2025: 8.73%
- Jun 2025: 8.77%
- Mar 2025: 8.87%
Public holding remains stable with consistent retail participation.
Sun Pharmaceutical Industries Ltd Government Holding
Government holding in Sun Pharmaceutical Industries Ltd currently stands at 0.00%.
Sun Pharmaceutical Industries Ltd operates without significant government ownership.
Sun Pharmaceutical Industries Ltd Shareholding Analysis Summary
The Sun Pharmaceutical Industries Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Sun Pharmaceutical Industries Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.
Regular monitoring of the Sun Pharmaceutical Industries Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.